Helperby Therapeutics Group Limited, a private pharmaceutical company, has recently signed a significant agreement with GEM Global Yield LLC SCS, a private alternative investment group based in Luxembourg. The agreement includes an investment of up to $75 million within 3 years of any public listing. The investment will support Helperby’s mission to develop multiple new antibiotic products to…
